KINETIC AND INHIBITION STUDIES ON CATECHOL-O-METHYLTRANSFERASE AFFINITY LABELING BY N-(3,4-DIHYDROXYPHENYL)MALEIMIDE

被引:4
|
作者
PIEDRAFITA, FJ
FERNANDEZALVAREZ, E
NIETO, O
TIPTON, KF
机构
[1] CSIC,INST QUIM ORGAN GEN,JUAN CIERVA 3,E-28006 MADRID,SPAIN
[2] UNIV DUBLIN TRINITY COLL,DEPT BIOCHEM,DUBLIN 2,IRELAND
关键词
D O I
10.1042/bj2860951
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Initial velocity and product inhibition studies have been performed on soluble catechol-O-methyltransferase which has been partially purified from pig liver. The results are consistent with an ordered reaction mechanism, in which S-adenosyl-L-methionine (AdoMet) is the leading substrate. The enzyme is irreversibly inhibited by maleimide derivatives in a biphasic manner, which suggests a differential reaction with two thiol groups. N-(3,4-Dihydroxyphenyl)maleimide, which has a reactive moiety (maleimide ring) and an affinity moiety (catechol ring), acts as an affinity labelling compound on the more reactive SH group; AdoMet and Mg2+ protect against this modification. Total protection of this SH group results in a pseudo-first-order inhibition of the enzyme, with the apparent rate constant being proportional to the inhibitor concentration. All the other maleimide derivatives studied inhibited the enzyme by reacting with one of the two SH groups in a non-specific manner. The reaction of the other, more reactive. SH group was either specific (active-site-directed) or non-specific, depending on the substituent present in the affinity moiety and also on the length of an intermediate chain of methylene groups present between this moiety and the reactive maleimide ring. In the presence of both AdoMet and Mg2+, 3,5-dinitrocatechol, a reversible inhibitor of the enzyme which is competitive with respect to the catechol substrate, protects the enzyme from inactivation by any of the maleimide derivatives. The adducts of these maleimide derivatives formed with dithiothreitol inhibit the enzyme reversibly, showing inhibition patterns that are consistent with the mechanism deduced from the initial velocity and product inhibition studies.
引用
收藏
页码:951 / 958
页数:8
相关论文
共 50 条
  • [31] Kinetic inhibitory profile of BIA 3-202, a novel fast tight-binding, reversible and competitive catechol-O-methyltransferase inhibitor
    Bonifácio, MJ
    Vieira-Coelho, MA
    Soares-da-Silva, P
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2003, 460 (2-3) : 163 - 170
  • [32] INHIBITION OF CATECHOL-O-METHYLTRANSFERASE BY 6,7-DIHYDROXY-3,4-DIHYDROISOQUINOLINES RELATED TO DOPAMINE - DEMONSTRATION USING LIQUID-CHROMATOGRAPHY AND A NOVEL SUBSTRATE FOR O-METHYLATION
    CHENG, BY
    ORIGITANO, TC
    COLLINS, MA
    JOURNAL OF NEUROCHEMISTRY, 1987, 48 (03) : 779 - 786
  • [33] Synergistic inhibition of lung cancer cell lines by ()-epigallocatechin-3-gallate in combination with clinically used nitrocatechol inhibitors of catechol-O-methyltransferase
    Forester, Sarah C.
    Lambert, Joshua D.
    CARCINOGENESIS, 2014, 35 (02) : 365 - 372
  • [34] Use of catechol-O-methyltransferase inhibition to minimize L-3,4-dihydroxyphenylalanine-induced dyskinesia in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned macaque
    Huot, Philippe
    Johnston, Tom H.
    Snoeren, Tessa
    Koprich, James B.
    Hill, Michael P.
    Fox, Susan H.
    Brotchie, Jonathan M.
    EUROPEAN JOURNAL OF NEUROSCIENCE, 2013, 37 (05) : 831 - 838
  • [35] REDUCTION OF CIRCULATING 3-O-METHYLDOPA BY INHIBITION OF CATECHOL-O-METHYLTRANSFERASE WITH OR-611 AND OR-462 IN CYNOMOLGUS MONKEYS - IMPLICATIONS FOR THE TREATMENT OF PARKINSONS-DISEASE
    CEDARBAUM, JM
    LEGER, G
    GUTTMAN, M
    CLINICAL NEUROPHARMACOLOGY, 1991, 14 (04) : 330 - 342
  • [36] Identification of N-[3-(3,4-Dihydroxyphenyl)-1-oxo-2-propenyl]-2-hydroxybenzamide (CGK-101) as a Small Molecule Inhibitor of the Wnt/β-catenin Pathway
    Park, Seoyoung
    Lee, Jee-Hyun
    Lee, Jung Sook
    Song, Gyu-Yong
    Oh, Sangtaek
    BULLETIN OF THE KOREAN CHEMICAL SOCIETY, 2013, 34 (04) : 1286 - 1289
  • [37] N-SUBSTITUTED DOPAMINE AND 2-AMINO-6,7-DIHYDROXY-1,2,3,4-TETRAHYDRONAPHTHALENE ANALOGS AS SUBSTRATES FOR CATECHOL-O-METHYLTRANSFERASE
    GINOS, JZ
    STEVENS, JM
    DHAR, AK
    BENCSATH, AS
    FEDERATION PROCEEDINGS, 1980, 39 (03) : 754 - 754
  • [38] Concerted action of the cytosolic sulfotransferase, SULT1A3, and catechol-O-methyltransferase in the metabolism of dopamine in SK-N-MC human neuroblastoma cells
    Yasuda, Shin
    Yasuda, Tomoko
    Hui, Ying
    Liu, Ming-Yih
    Suiko, Masahito
    Sakakibara, Yoichi
    Liu, Ming-Cheh
    NEUROSCIENCE RESEARCH, 2009, 64 (03) : 273 - 279
  • [39] Synthesis of 1-(3,4-dihydroxy-5-nitrophenyl)-2-phenyl-ethanone and derivatives as potent and long-acting peripheral inhibitors of catechol-O-methyltransferase
    Learmonth, DA
    Vieira-Coelho, MA
    Benes, J
    Alves, PC
    Borges, N
    Freitas, AP
    Soares-Da-Silva, P
    JOURNAL OF MEDICINAL CHEMISTRY, 2002, 45 (03) : 685 - 695
  • [40] Studies on the Inhibition of Ectonucleotide Pyrophosphatase/Phosphodiesterase 1 (ENPP1) by 2-(3,4-Dihydroxyphenyl)-7,8-dihydroxy-3-methoxychromen-4-one, a Flavonoid from Pistacia chinensis
    Rauf, Abdur
    Akram, Zuneera
    Naveed, Muhammad
    Almasoud, Najla
    Alomar, Taghrid S.
    Saleem, Muhammad
    Waheed, Abdul
    Ribaudo, Giovanni
    CHEMISTRY-SWITZERLAND, 2023, 5 (04): : 2094 - 2103